We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Floating cells with transparent membranes.
Industry Insight

Unlocking the “Morpholome” With AI-Powered Imaging

Technology Networks had the pleasure of speaking with Dr. Maddison Masaeli, co-founder and chief executive officer at Deepcell to learn about the REM-I platform, a single-cell analysis tool that utilizes AI-powered imaging to magnify insights into a cell’s phenotype and function.
Photograph of the Agilent Measurement Suite at Imperial College London taken through the window.
Industry Insight

Flagship Facility Supports Advanced Analytical Science

We spoke to Prof. Oscar Ces, head of the Department of Chemistry at Imperial College London (ICL), to find out about the evolution of ICL’s White City Campus, the Agilent Measurement Suite and what it means for scientists across the board.
Liver cells as seen under a microscope.
Industry Insight

Curing the Image Analysis Headache with Deep Learning

Misha Bashkurov explores how image analysis software with deep learning capabilities can directly address the convoluted and confusing process of traditional image analysis, which often leads to user frustration, bias results, time lost and increased costs.
DNA double helix on a blue background.
Industry Insight

You Have No Moat – The Great AI Democratization Spells New Challenges and Opportunities for SynBio Companies

This article examines the impact of the democratization of computational design and discusses how synthetic biology companies must shift focus if they are to remain competitive.
Four drug tablets lined up.
Industry Insight

Data-Driven Adaptive Trials: Enhancing Safety, Accelerating Progress and Boosting Economics Through Enhanced Insights

Trial sponsors are faced with vast amounts of diverse data and corresponding endpoints spanning all trial sites linked to their study design. This article explores how interactive response technology can help sponsors overcome these challenges.
A computer chip with the text "AI"
Industry Insight

Applying AI Across All Stages of Drug Development

To learn more about the application of AI across all stages of development, from drug design to clinical trials, Technology Networks spoke with Dr. Yuan Wang, head of research analytics at UCB.
Cogs with business strategy icons representing success and innovation.
Industry Insight

Change Management’s Impact on Innovation in the Pharma QC Laboratory

Change management is becoming an increasingly important part of company culture. This article explores how effective change management can reap significant benefits.
Human face looking at an artificial intelligence face.
Industry Insight

Digital Twins and Trial Arms: Is the Future of Single-Arm Oncology Trials Already Here?

In this opinion piece, Dr. Gen Li discusses how AI and predictive analytics are transforming oncology clinical trials.
An image of a robot meeting a human hand.
Industry Insight

Supporting Reproducibility and Accelerating Workflows With Automated Systems

At SLAS 2023, Technology Networks spoke with the PerkinElmer Life Sciences and Diagnostics organization to discuss the launch of two new automated platforms. These innovative systems are designed to improve workflows such as high-throughput drug discovery screening and next-generation sequencing library prep through advances in automation technologies.
A sketch depicting the idea of automation and connection in the lab.
Industry Insight

Connectivity, Flexibility and Integration in the Automated Lab

Through automating processes and workflows, scientists can optimize their time and concentrate on high-value tasks. At SLAS 2023, Technology Networks interviewed Lars Kristiansen, general manager of Agilent’s Automation Solutions Business. We discussed Agilent’s automation portfolio that was showcased at the event, in addition to trends and challenges in automation.
Advertisement